Hyperphosphatemia Features

The Medical Minute Calcium-Based Phosphate Binders Up Death Risk

Calcium-Based Phosphate Binders Up Death Risk

Patients who take phosphate binders may be at a 22% higher risk of death that those who take other non-calcium based treatments.

CME Articles Parathyroid Hormone, Alkaline Phosphatase and Fibroblast Growth Factor 23

Parathyroid Hormone, Alkaline Phosphatase and Fibroblast Growth Factor 23

The management of chronic kidney disease-mineral bone disorder (CKD-MBD) is central to the care of patients with kidney disease.

Latest Hyperphosphatemia News

Ferric Citrate Approved for Phosphorus Control in Chronic Kidney Disease (CKD) Patients

Ferric Citrate Approved for Phosphorus Control in Chronic Kidney Disease (CKD) Patients

In addition to reducing serum phosphorus levels to within the recommended range, ferric citrate increases iron stores.

Novel Binder Lowers Phosphate with Fewer Pills

Novel Binder Lowers Phosphate with Fewer Pills

In a study, PA21 was as efficacious as sevelamer carbonate, but patients taking PA21 had a lower pill burden and better adherence.

Elevated Phosphorus May Increase Death Risk

Elevated Phosphorus May Increase Death Risk

Researchers observed the association among individuals with serum phosphorus levels measured after fasting for 12 or more hours.

Hospitalization Costs Lower with Ferric Citrate

Hospitalization Costs Lower with Ferric Citrate

Use is associated with fewer hospitalizations versus sevelamer carbonate and calcium acetate.

Phosphorus Control Using PTH Tested

Phosphorus Control Using PTH Tested

In mice with and without CKD, phosphorus levels decreased by an average of 35% by 6 hours after injection with long-acting PTH.

Lower Phosphorus, Higher Protein Intake Improve Survival

Lower Phosphorus, Higher Protein Intake Improve Survival

Protein levels found to modify the effect of serum phosphorus with mortality in hemodialysis patients.

No Clinically Relevant Changes in Vitamin D with PA21

No Clinically Relevant Changes in Vitamin D with PA21

Researchers compared the novel iron-based phosphate binder with sevelamer.

Team-Focused Approach Improves Phosphorus Control

Team-Focused Approach Improves Phosphorus Control

In a study, nurses and technicians educated groups of hemodialysis patients about phosphate binders.

Multi-Prong Approach Has Little Effect on Phosphorus Control

Multi-Prong Approach Has Little Effect on Phosphorus Control

Researchers tested an intervention that included an educational fair, phosphorus group social, and staff education on phosphate binders.

Limiting Phosphorus Additives Aids Phosphatemia Control

Limiting Phosphorus Additives Aids Phosphatemia Control

Researchers observed reduced phosphorus levels in HD patients whose diet restricted intake of phosphorus additives.

Phosphorus Changes Affect Dialysis Patient Mortality Risk

Declines in serum phosphorus over time may improve survival.

Higher PTH and Dietary Protein Intake Hikes Hyperphosphatemia Risk

Worsening or resistant hyperphosphatemia may be an under-appreciated consequence of secondary hyperparathyroidism.

Phosphate Binders Offer No Short-Term Mortality Benefit

Calcium-based and non-calcium-based binder use were associated with similar death risks.

Limiting Phosphorus Additives in Foods Lowers Serum Phosphorus

Levels declined significantly from 7.2 to 5.0 mg/dL, data show.

Vascular Calcification Linked to Lower Phosphate Clearance

Vascular calcification contributes to increased cardiovascular risk in dialysis patients.